A clinical trial shows a Covid-19 vaccine taken as a tablet produces protective antibodies in nasal membranes that in some cases last for up to a year. . . . → Read More: Trial Shows Oral Covid-19 Vaccine Produces Antibodies
|
|||||
A clinical trial shows a Covid-19 vaccine taken as a tablet produces protective antibodies in nasal membranes that in some cases last for up to a year. . . . → Read More: Trial Shows Oral Covid-19 Vaccine Produces Antibodies An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells. . . . → Read More: CEPI Funds New Broad Coronavirus Vaccine Large majorities of Americans now consider cyberattacks and disinformation online as their main worldwide threats, according to a recent poll. . . . → Read More: Infographic – Cyberattacks Rated Top Global Threat New data from the U.S. Bureau of Labor Statistics, displayed in chart form last week, indicate the work-from-home era may be closing. . . . → Read More: Infographic – US Workers Returning to Work A company applying artificial intelligence to drug discovery says it designed a new oral drug for Covid-19 infections that can be quickly produced. . . . → Read More: AI Drug Company Creating Covid-19 Therapy for Rapid Delivery A collaboration between developers of protein analytics and test-strip diagnostics aims to create a quicker, more sensitive, easy-to-use Covid-19 detection test. . . . → Read More: Partnership Developing Faster, Sensitive Covid-19 Test Lab studies show an experimental synthetic antibody protects animals and neutralizes all SARS-CoV-2 variants of concern, including omicron BA.2. . . . → Read More: Preclinical Tests Show Antibody Stops Covid-19 Variants A study with a small chip device simulating human lung functions shows normal breathing generates immune responses that protect against respiratory diseases. . . . → Read More: Lung Chip Reveals Respiratory Immune Responses A company developing a needle patch for vaccine delivery is acquiring the rights to a synthetic SARS-Cov-2 spike protein for its Covid-19 vaccine patch. . . . → Read More: Univ. Lab Licenses Protein for Vaccine Patch Findings from research with older lab mice show an oral drug addressing immune deficiencies protects the mice from death by SARS-CoV-2 infections. . . . → Read More: Preclinical Study Shows Immune Drug Prevents Covid-19 Death |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |